RYAN ARTHUR F sold 0.6% of their position (100.00 shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $70.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−5.00
Price / share
$701.76
Trade value
$3.51K
% of position
Common Stock
Shares
−15.00
Price / share
$702.46
Trade value
$10.54K
% of position
Common Stock
Shares
−24.00
Price / share
$703.46
Trade value
$16.88K
% of position
Common Stock
Shares
−15.00
Price / share
$704.28
Trade value
$10.56K
% of position
Common Stock
Shares
−14.00
Price / share
$705.56
Trade value
$9.88K
% of position
Common Stock
Shares
−7.00
Price / share
$706.74
Trade value
$4.95K
% of position
Common Stock
Shares
−4.00
Price / share
$707.40
Trade value
$2.83K
% of position
Common Stock
Shares
−6.00
Price / share
$709.45
Trade value
$4.26K
% of position
Common Stock
Shares
−2.00
Price / share
$710.87
Trade value
$1.42K
% of position
Common Stock
Shares
−5.00
Price / share
$711.49
Trade value
$3.56K
% of position
Common Stock
Shares
−1.00
Price / share
$712.09
Trade value
$712.09
% of position
Common Stock
Shares
−2.00
Price / share
$714.13
Trade value
$1.43K
% of position
Net shares
−100.00
Net value
-$70.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −5.00 | $701.76 | $3.51K | 0.0% | 17.60K | 17.60K |
| Common Stock Direct | 5/1/2026 | S · Sale | −15.00 | $702.46 | $10.54K | 0.1% | 17.60K | 17.58K |
| Common Stock Direct | 5/1/2026 | S · Sale | −24.00 | $703.46 | $16.88K | 0.1% | 17.58K | 17.56K |
| Common Stock Direct | 5/1/2026 | S · Sale | −15.00 | $704.28 | $10.56K | 0.1% | 17.56K | 17.54K |
| Common Stock Direct | 5/1/2026 | S · Sale | −14.00 | $705.56 | $9.88K | 0.1% | 17.54K | 17.53K |
| Common Stock Direct | 5/1/2026 | S · Sale | −7.00 | $706.74 | $4.95K | 0.0% | 17.53K | 17.52K |
| Common Stock Direct | 5/1/2026 | S · Sale | −4.00 | $707.40 | $2.83K | 0.0% | 17.52K | 17.52K |
| Common Stock Direct | 5/1/2026 | S · Sale | −6.00 | $709.45 | $4.26K | 0.0% | 17.52K | 17.51K |
| Common Stock Direct | 5/1/2026 | S · Sale | −2.00 | $710.87 | $1.42K | 0.0% | 17.51K | 17.51K |
| Common Stock Direct | 5/1/2026 | S · Sale | −5.00 | $711.49 | $3.56K | 0.0% | 17.51K | 17.51K |
| Common Stock Direct | 5/1/2026 | S · Sale | −1.00 | $712.09 | $712.09 | 0.0% | 17.51K | 17.50K |
| Common Stock Direct | 5/1/2026 | S · Sale | −2.00 | $714.13 | $1.43K | 0.0% | 17.50K | 17.50K |
| Total | −100.00 | -$70.52K | ||||||